Correspondence 0001213900-25-118092 from Allarity Therapeutics, Inc. (ALLR)
Allarity Therapeutics, Inc.
Date: Dec. 4, 2025 · CIK: 0001860657 · Accession: 0001213900-25-118092
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-291906
Letter
Re: Allarity Therapeutics, Inc.
VIA EDGAR
December 4, 2025
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Registration Statement on Form S-3
File No. 333-291906
Acceleration Request
Requested Date: December 5, 2025
Requested Time: 4:00 p.m., Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Act"), Allarity Therapeutics, Inc. (the "Company") hereby requests the Securities and Exchange Commission take appropriate action to cause the above-referenced registration statement (the "Registration Statement") to become effective on December 5, 2025, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Venable LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Venable LLP, by calling William N. Haddad at (212) 503-9812 or, in his absence, Arif Soto at (212) 503-0874.
Very truly yours,
ALLARITY THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm VIA EDGAR December 4, 2025 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Allarity Therapeutics, Inc. Registration Statement on Form S-3 File No. 333-291906 Acceleration Request Requested Date: December 5, 2025 Requested Time: 4:00 p.m., Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Act"), Allarity Therapeutics, Inc. (the "Company") hereby requests the Securities and Exchange Commission take appropriate action to cause the above-referenced registration statement (the "Registration Statement") to become effective on December 5, 2025, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Venable LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. Once the Registration Statement is effective, please orally confirm the event with our counsel, Venable LLP, by calling William N. Haddad at (212) 503-9812 or, in his absence, Arif Soto at (212) 503-0874. Very truly yours, ALLARITY THERAPEUTICS, INC. By: /s/ Thomas H. Jensen Name: Thomas H. Jensen Title: Chief Executive Officer cc: William N. Haddad, Venable LLP Arif Soto, Venable LLP